A 61-Year-Old Man With Acute Graft-Versus-Host Disease
Advertisement
Advertisement
Trending on Targeted Onc
1
FDA Accepts sNDA for Gedatolisib in PIK3CA-Mutated HR+/HER2– Breast Cancer
2
COA Backs 340B Payment Cut in 2027 Final Rules, Warns of Physician Cuts
3
Obrixtamig Shows Activity in First-Line epNEC, Regardless of DLL3 Expression Level
4
Imneskibart Regimens Show Activity in ICI-Refractory Melanoma, NSCLC
5